Search Results
Results found for "GPCR Drug Discovery"
- 🎧 Why Does GPCR Location Make All the Difference? GPCR location within the cell can change everything: function, pharmacology, and even drug response. In Ep.162 of the Dr.GPCR Podcast, Dr. Gabriele Kockelkoren dives into: 🔬 How GPCR trafficking shapes signaling outcomes 🚀 Career insights from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug hunters, and anyone fascinated by GPCRs! 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast ✅ Tune in today! | Dr. GPCR Ecosystem
GPCR location within the cell can change everything: function, pharmacology, and even drug response. from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug GPCR Podcast 🎧 Why Does GPCR Location Make All the Difference? GPCR location within the cell can change everything: function, pharmacology, and even drug response. from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug
- We’re excited to announce our strategic partnership with Celtarys Research, a biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive GPCR assays. This collaboration combines Dr. GPCR’s global platform with Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery. We’re proud to welcome Celtarys to the Dr. GPCR ecosystem to support researchers worldwide and expand access to high-performance tools for GPCR-targeted therapeutics. ✳️Read the complete press release: https://www.ecosystem.drgpcr.com/post/dr-gpcr-and-celtarys-research-join-forces-to-expand-access-to-innovative-gpcr-tools #GPCR #DrGPCR #CeltarysResearch #DrugDiscoveryTools #FluorescentLigands #GPCRresearch #ScientificPartnership | Dr. GPCR Ecosystem
scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery. GPCR ecosystem to support researchers worldwide and expand access to high-performance tools for GPCR-targeted for scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery And that’s exactly what carries strong discovery programs into 2026. Dr. Yet discovery teams routinely lose time and misallocate resources because the underlying biology behaves
- Chris Langmead | Dr. GPCR Ecosystem
Chris Langmead is Professor, Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery ) and is the co-founder and CEO of Phrenix Therapeutics, a biotech spin-out from the Neuromedicines Discovery He is an acknowledged expert in drug discovery, particularly in the field of psychiatry, where he has He has published over 70 research articles, reviews and book chapters on drug discovery, which have been GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- terrys corner predict drug behavior | Dr. GPCR Ecosystem
Home → Flash News → terrys corner predict drug behavior Published on July 12, 2025 Category Terry's Corner Dive into the logic of drug modeling with Terry Kenakin. Learn to “extend your eyes” and predict complex drug behaviors. 🟢 Browse the full catalog (and expect ✳️ https://www.terrykenakin.com #pharmacology #drugmechanism #kenakin #GPCR #DrGPCR Previous Next Recent
- Eleonora Comeo | Dr. GPCR Ecosystem
Eleonora Comeo About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in the joint program of the University of Nottingham in the UK and Monash University in Australia We sat down to chat about GPCRs, synthesizing labeled ligands, and her unique position that allows her to work with GPCR scientists on 2 continents. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
Aurélien Rizk is a scientist and entrepreneur in drug discovery. Before focusing on the development of innovative mathematical modeling and simulation methods for drug discovery, Dr. Aurelien Rizk, a co-founder and CEO of Interax Biotech, shared about the company's development of a discovery Aurelien Rizk confirmed his attendance at the upcoming GPCR-Targeted Drug Discovery Summit in Boston.
- Revvity | Dr. GPCR Ecosystem
in life science innovation, delivering tools and technologies that bridge the gap between discovery unwavering focus on precision, Revvity empowers scientists to simplify complex workflows, accelerate discovery designing the next generation of therapeutics, Revvity isn’t just a provider—they’re your partner in discovery GPCR, the global nonprofit platform dedicated to advancing GPCR research and drug discovery, is proud Learn how pH Sense changes the game for drug discovery. Dr.
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
Additionally, they have a library of target GPCR heteromers for Oncology. Dr. Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing She oversaw early discovery programs IL-23 p19 and IL23 p19/IL-17 bispecifics. She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- terrys corner model drug response | Dr. GPCR Ecosystem
Home → Flash News → terrys corner model drug response Published on July 10, 2025 Category Terry's Corner What if a single experimental snapshot could predict an entire in vivo drug profile in a range of organs discussed. 🟢 Read the full breakdown: ✳️ https://www.ecosystem.drgpcr.com/post/what-if-you-could-predict-drug-behavior-with-just-a-snapshot #GPCR #DrGPCR #pharmacology #DrugDiscovery #TerryKenakin #FoundationalScience Previous Next Recent Articles
- Class B GPCR drugs are reshaping treatment for migraine, diabetes, and obesity- but did you know ligand bias plays a key role in their success? This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock next-gen therapies. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/reviews/where-are-we-now%3F-biased-signalling-of-class-b-g-protein-coupled-receptor-targeted-therapeutics #gpcr#drgpcr | Dr. GPCR Ecosystem
Home → Flash News → Class B GPCR drugs are reshaping treatment for migraine, diabetes, and obesity- but This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com #drgpcr Published on June 2, 2025 Category GPCR Weekly News Class B GPCR drugs are reshaping treatment This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks
- You never know where your GPCR takes you with Dr. Brian Hudson | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) You never know where your GPCR takes you with Dr. He has more than 20 years of experience in GPCR, primarily focused on drug discovery and developing new leads a research group that is focused on understanding the pharmacology and function of a group a GPCRs GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
PARs are GPCRs that are activated through an atypical irreversible proteolytic mechanism. biology and for the identification of drug targets and future drug development. which has important functions in hemostasis, thrombosis, inflammation, and cancer and is an important drug She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
His current focus is to realise Antiverse’s mission: engineering the future of drug discovery." Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter GPCR About Ben Holland "Ben gained his masters in Engineering Science from Oxford, taking a specialisation GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks
- Media Partner Packages | Dr. GPCR Ecosystem
GPCR Ecosystem. partner, you'll gain trusted access to an engaged audience of academic researchers, biotech teams, and drug discovery innovators—without having to fight for attention. GPCR? GPCR platform as a valued partner ✓ Share insights on product launches, scientific discoveries, or customer
- pharmacology at your fingertips terrys corner launches | Dr. GPCR Ecosystem
Flash News → pharmacology at your fingertips terrys corner launches Published on July 4, 2025 Category GPCR Weekly News Stronger pharmacology drives smarter decisions in GPCR discovery. Elevate your drug discovery program with 45+ lessons yearly. GPCR Weekly: ♦️ Yamina’s Corner—GPCR consulting to de-risk and accelerate your pipeline ♦️ Celtarys’ validated TR-FRET assay for CB1/CB2 ♦️ Chemokine-GPCR selectivity decoded ♦️ PTH1R structures reveal
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program Our first main research aspect is the identification of endogenous ligand of GPCRs. Our third main research aspect is working mechanism of GPCR. Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR (Cell 2021, 2023, Nature 2023b), bile acids or its derivatives by GPCRs (Nature 2020)."
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially GPCR. In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Enjoying the Dr. GPCR Podcast?
- Robert Laprairie | Dr. GPCR Ecosystem
Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Better Questions in Science: A Practical Guide for Emerging Researchers When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and discovery. his mentors and significant discoveries related to allosteric receptors. discovery. Allosteric Modulation and Drug Discovery Yamina and Arthur delved into the complexities of protein-protein
- Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program signaling pathway of the ADGRA homolog Remoulade in Drosophila Beatriz Blanco Redondo The Adhesion GPCR The mammalian Remo homolog ADGRA2/Gpr124 cooperates with other GPCRs of the Frizzled family, and the Anaesthesiology and Intensive Care, Medical Faculty, Leipzig University, Leipzig, Germany 5 Institute for Drug Discovery, Faculty of Medicine, Leipzig University 6 School of Medicine, University of Global Health
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
Specifically, I am interested in understanding dysregulated G-protein coupled receptor (GPCR) signaling Traditional drug discovery efforts have focused on agonists and antagonists that bind to the orthosteric My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs. ubiquitous class of plasma membrane receptors and serve as targets for more than one-third of all prescribed drugs GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.
- Generic tools won’t solve tomorrow’s drug discovery challenges. That’s why Celtarys designs custom fluorescent probes for every target, built for real pharmacology, not just convenience. With Dr. GPCR and Celtarys joining forces, expect more visibility, more precision, and more scientific impact. 🚀 Get to know our media partner: https://www.ecosystem.drgpcr.com/celtarys-research-dr-gpcr-ecosystem #GPCRdrugDiscovery #GPCRecosystem #CustomLigands | Dr. GPCR Ecosystem
Home → Flash News → Generic tools won’t solve tomorrow’s drug discovery challenges. CustomLigands Published on June 27, 2025 Category Celtarys - Media Partner Generic tools won’t solve tomorrow’s drug discovery challenges. And that’s exactly what carries strong discovery programs into 2026. Dr. Yet discovery teams routinely lose time and misallocate resources because the underlying biology behaves
- Dr. Kari Johnson | Dr. GPCR Ecosystem
University before continuing her training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol All through her career, the recurring theme in Kari’s work has been GPCRs and more specifically Metabotropic Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.
- How GPCR Collaboration Built an Innovation Engine | Dr. GPCR Ecosystem
GPCR collaboration at Monash shows how shared lab ecosystems can reshape innovation and accelerate drug discovery. Home → Flash News → How GPCR Collaboration Built an Innovation Engine How GPCR Collaboration Built an And that’s exactly what carries strong discovery programs into 2026. Dr. Yet discovery teams routinely lose time and misallocate resources because the underlying biology behaves
- Scott Struthers | Dr. GPCR Ecosystem
he led contract research efforts at Biosym Technologies to develop and apply computational tools for drug discovery. co-founded and serves as board chair at Radionetics Oncology, a pharmaceutical company focused on the discovery GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks
- ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem
AI is transforming GPCR modeling. scientists to go beyond explaining data — and start predicting the future of receptor function and drug discovery. News → ep 175 with jens carlsson clip 3 AI is changing how we think about structure, function, and discovery GPCR Podcast AI is changing how we think about structure, function, and discovery — but Jens Carlsson
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
This made me pursue my higher education in the field of adhesion GPCRs. Emmanouil Kyrloglou on the web Adhesion GPCR Consortium LinkedIn A single cell GPCR map of thermogenic , located within the GPCR autoproteolysis inducing (GAIN) domain. University" About Jesse Stillwell "Jesse Stillwell is a 3rd year graduate student with a research focus in drug His project is drug discovery focused, with particular interest in use of a novel epigenetic therapy
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
and the immune system, and the molecular mechanisms underlying the signaling and regulation of their GPCRs Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Better Questions in Science: A Practical Guide for Emerging Researchers When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks
- Dr. David E. Gloriam | Dr. GPCR Ecosystem
Computational Receptor Biology at the University of Copenhagen where he leads a research cluster for GPCR function and drug discovery and a Pharmaceutical Data Science unit. one of the coordinators of recommendations to describe ligand bias towards signaling probes and safer drugs GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks


















